Sweet antibiotics – the role of glycosidic residues in antibiotic and antitumor activity and their randomization
- 1 August 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in FEMS Microbiology Reviews
- Vol. 32 (5), 858-889
- https://doi.org/10.1111/j.1574-6976.2008.00124.x
Abstract
A large number of antibiotics are glycosides. In numerous cases the glycosidic residues are crucial to their activity; sometimes, glycosylation only improves their pharmacokinetic parameters. Recent developments in molecular glycobiology have improved our understanding of aglycone vs. glycoside activities and made it possible to develop new, more active or more effective glycodrugs based on these findings - a very illustrative recent example is vancomycin. The majority of attention has been devoted to glycosidic antibiotics including their past, present, and probably future position in antimicrobial therapy. The role of the glycosidic residue in the biological activity of glycosidic antibiotics, and the attendant targeting and antibiotic selectivity mediated by glycone and aglycone in antibiotics some antitumor agents is discussed here in detail. Chemical and enzymatic modifications of aglycones in antibiotics, including their synthesis, are demonstrated on various examples, with particular emphasis on the role of specific and mutant glycosyltransferases and glycorandomization in the preparation of these compounds. The last section of this review describes and explains the interactions of the glycone moiety of the antibiotics with DNA and especially the design and structure-activity relationship of glycosidic antibiotics, including their classification based on their aglycone and glycosidic moiety. The new enzymatic methodology 'glycorandomization' enabled the preparation of glycoside libraries and opened up new ways to prepare optimized or entirely novel glycoside antibiotics.Keywords
This publication has 150 references indexed in Scilit:
- Optimizing Glycosyltransferase Specificity via “Hot Spot” Saturation Mutagenesis Presents a Catalyst for Novobiocin GlycorandomizationCell Chemical Biology, 2008
- A Post-PKS Oxidation of the Amphotericin B Skeleton Predicted to be Critical for Channel Formation Is Not Required for Potent Antifungal ActivityJournal of the American Chemical Society, 2007
- Carbohydrate-Based DNA Ligands: Sugar−Oligoamides as a Tool to Study Carbohydrate−Nucleic Acid InteractionsJournal of the American Chemical Society, 2005
- Aminoglycoside binding in the major groove of duplex RNA: the thermodynamic and electrostatic forces that govern recognitionJournal of Molecular Biology, 2000
- Scavenging Byproducts in the Sulfoxide Glycosylation Reaction: Application to the Synthesis of Ciclamycin 0Journal of the American Chemical Society, 1999
- Reconstruction of Vancomycin by Chemical Glycosylation of the PseudoaglyconJournal of the American Chemical Society, 1998
- Solution structure of the esperamicin A1-DNA complexJournal of Molecular Biology, 1997
- The Deoxyfucose-Anthranilate of Esperamicin A1 Confers Intercalative DNA Binding and Causes a Switch in the Chemistry of Bistranded DNA LesionsJournal of the American Chemical Society, 1994
- DNA-drug interactions: The crystal structure of d(CGATCG) complexed with daunomycinJournal of Molecular Biology, 1989
- Erythromycin. II. Des-N-methylerythromycin and N-Methyl-C14-erythromycinJournal of the American Chemical Society, 1955